TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
ELTX

Elicio Therapeutics Inc.

Healthcare · Biotechnology

1.90$ +5.4% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Elicio Therapeutics Inc. (ELTX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 73.0% of the shares are freely tradable; institutional investors hold 17.0%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 17.0%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 29.8%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 73.0%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 7.8%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 26Mio.

Largest Shareholders

Institutions

Institutions ELTX
Name Stake (%) Shares Change (%) Date
Knoll Capital Management LP 2.40 630,915 +0.0 03/31/2026
Vanguard Capital Management, LLC 1.97 518,638 +0.0 03/31/2026
Balyasny Asset Management LLC 0.93 244,814 +76.4 03/31/2026
Geode Capital Management, LLC 0.51 135,164 +2.0 03/31/2026
Renaissance Technologies Corp 0.46 121,631 +332.7 03/31/2026

Funds

Funds ELTX
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 1.58 415,401 +0.0 07/31/2026
iShares Russell 2000 ETF 1.19 313,939 -0.6 08/31/2026
Vanguard Institutional Extnd Mkt Idx Tr 0.55 143,596 +0.0 07/31/2026
Fidelity Small Cap Index 0.53 139,903 +0.0 06/30/2026
iShares Russell 2000 Growth ETF 0.47 122,625 +0.0 08/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?